Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on May 17, 2017.
November 17, 2017 at 12:29 pm IST
Share
From July 1, 2017 to November 17, 2017, the company has repurchased 49,426 shares, representing 0.97% for KRW 1,218.15 million. With this, the company has completed the repurchase of 82,172 shares, representing 1.6% for KRW 1,993.68 million under the buyback announced on May 17, 2017.
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.